Clinical trial
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in…
NCT00199836 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00199836 |
|---|---|
| Title | A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. |
| Official title | A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1. |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Neoplasm |
| Intervention type | Biological |
| Interventions | NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51 |
| Enrollment | 14 |
| Start date | Sep 3, 2003 |
| Primary completion | Sep 5, 2005 |
| Completion | Jun 6, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 10, 2022 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: